Dear Doctor - Participate in the Survey on lung cancer " A new survey has found that lung cancer is the leading cause of cancer death in both men and women in the United States. The survey, which was conducted by the American Cancer Society, found that lung cancer accounted for 27 percent of all cancer deaths in the US in 2014. This is higher than the next two most common causes of cancer death combined - breast cancer and colorectal cancer.Lung cancer is a particularly deadly form of cancer, with a five-year survival rate of just 18 percent. However, the ACS notes that there have been significant advances in treatment in recent years, and says that more people are surviving lung cancer than ever before.The ACS recommends that all adults aged 55 and over should get regular lung screenings, as well as those who are at high risk for lung cancer due to smoking or exposure to secondhand smoke. Participate in Surveys "
1.
Colon cancer and exercise: Can physical activity reprogram genes?
2.
For relapsed or resistant DLBCL, odronextamab produced positive results.
3.
Improved end-of-life conversations for cancer patients are identified by a new study.
4.
Another KRAS Inhibitor Scores an Early Win in Advanced Non-Small Cell Lung Cancer
5.
Xerostomia in Head and Neck Cancer Patients Can Be Predicted by Mid-Treatment PET/CT Scans.
1.
Treating Methemoglobinemia: What You Need to Know Now!
2.
Is AI The New Radiologist For Breast MRI?
3.
Advancements in Squamous Cell Carcinoma Treatment: Decoding Survival Strategies and Molecular Pathways to Improve Cure Rates
4.
Unlocking the Potential of Pirtobrutinib: A New Frontier in Cancer Treatment
5.
Unleashing the Oncolytic Arsenal: Talimogene Laherparepvec Monotherapy – A Targeted Cancer Immunotherapy Treatment
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Breaking Down PALOMA-2: How CDK4/6 Inhibitors Redefined Treatment for HR+/HER2- Metastatic Breast Cancer
2.
Newer Immunotherapies for Myeloma- A Comprehensive Overview- Part II
3.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session
4.
Current Scenario of Cancer- An Overview of The Incidence of Cancer in Men
5.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation